Charles Schwab’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
2,289,929
+168,405
| +8% | +$209K | ﹤0.01% | 2569 |
|
|
2025
Q1 | $2.5M | Sell |
2,121,524
-54,728
| -3% | -$64.6K | ﹤0.01% | 2540 |
|
|
2024
Q4 | $3.98M | Buy |
2,176,252
+135,949
| +7% | +$249K | ﹤0.01% | 2442 |
|
|
2024
Q3 | $3.47M | Buy |
2,040,303
+82,807
| +4% | +$141K | ﹤0.01% | 2536 |
|
|
2024
Q2 | $2.68M | Sell |
1,957,496
-30,023
| -2% | -$41.1K | ﹤0.01% | 2598 |
|
|
2024
Q1 | $7.45M | Buy |
1,987,519
+20,682
| +1% | +$77.6K | ﹤0.01% | 2130 |
|
|
2023
Q4 | $19.3M | Buy |
1,966,837
+127,855
| +7% | +$1.25M | ﹤0.01% | 1619 |
|
|
2023
Q3 | $15.4M | Buy |
1,838,982
+58,556
| +3% | +$489K | ﹤0.01% | 1661 |
|
|
2023
Q2 | $23.7M | Buy |
1,780,426
+40,017
| +2% | +$532K | 0.01% | 1377 |
|
|
2023
Q1 | $20.2M | Buy |
1,740,409
+160,015
| +10% | +$1.85M | 0.01% | 1470 |
|
|
2022
Q4 | $12.9M | Buy |
1,580,394
+28,287
| +2% | +$231K | ﹤0.01% | 1709 |
|
|
2022
Q3 | $9.01M | Sell |
1,552,107
-115,772
| -7% | -$672K | ﹤0.01% | 1902 |
|
|
2022
Q2 | $7.37M | Buy |
1,667,879
+39,937
| +2% | +$177K | ﹤0.01% | 1998 |
|
|
2022
Q1 | $14.8M | Buy |
1,627,942
+36,617
| +2% | +$333K | ﹤0.01% | 1732 |
|
|
2021
Q4 | $32.6M | Buy |
1,591,325
+145,480
| +10% | +$2.98M | 0.01% | 1207 |
|
|
2021
Q3 | $36.9M | Buy |
1,445,845
+11,545
| +0.8% | +$295K | 0.01% | 1075 |
|
|
2021
Q2 | $50.2M | Buy |
1,434,300
+72,151
| +5% | +$2.52M | 0.02% | 867 |
|
|
2021
Q1 | $45.4M | Buy |
1,362,149
+147,677
| +12% | +$4.92M | 0.02% | 905 |
|
|
2020
Q4 | $31.5M | Buy |
1,214,472
+82,859
| +7% | +$2.15M | 0.01% | 1065 |
|
|
2020
Q3 | $11.2M | Buy |
1,131,613
+183,424
| +19% | +$1.81M | 0.01% | 1617 |
|
|
2020
Q2 | $3.27M | Buy |
948,189
+65,560
| +7% | +$226K | ﹤0.01% | 2223 |
|
|
2020
Q1 | $2.7M | Buy |
882,629
+17,531
| +2% | +$53.6K | ﹤0.01% | 2144 |
|
|
2019
Q4 | $4.45M | Buy |
865,098
+17,401
| +2% | +$89.4K | ﹤0.01% | 2080 |
|
|
2019
Q3 | $4.38M | Buy |
847,697
+35,338
| +4% | +$182K | ﹤0.01% | 2030 |
|
|
2019
Q2 | $4.92M | Buy |
812,359
+27,447
| +3% | +$166K | ﹤0.01% | 1979 |
|
|
2019
Q1 | $5.68M | Buy |
784,912
+32,569
| +4% | +$235K | ﹤0.01% | 1921 |
|
|
2018
Q4 | $5.57M | Buy |
752,343
+78,493
| +12% | +$581K | ﹤0.01% | 1850 |
|
|
2018
Q3 | $3.65M | Buy |
673,850
+59,562
| +10% | +$322K | ﹤0.01% | 2208 |
|
|
2018
Q2 | $2.18M | Buy |
614,288
+95,551
| +18% | +$339K | ﹤0.01% | 2348 |
|
|
2018
Q1 | $1.06M | Buy |
518,737
+91,535
| +21% | +$188K | ﹤0.01% | 2496 |
|
|
2017
Q4 | $1.13M | Buy |
427,202
+18,564
| +5% | +$49K | ﹤0.01% | 2474 |
|
|
2017
Q3 | $2.15M | Buy |
408,638
+132,379
| +48% | +$695K | ﹤0.01% | 2260 |
|
|
2017
Q2 | $984K | Sell |
276,259
-77,558
| -22% | -$276K | ﹤0.01% | 2463 |
|
|
2017
Q1 | $1.83M | Buy |
353,817
+23,594
| +7% | +$122K | ﹤0.01% | 2230 |
|
|
2016
Q4 | $1.26M | Buy |
330,223
+31,859
| +11% | +$121K | ﹤0.01% | 2360 |
|
|
2016
Q3 | $2.67M | Buy |
298,364
+163,064
| +121% | +$1.46M | ﹤0.01% | 1997 |
|
|
2016
Q2 | $952K | Buy |
135,300
+19,300
| +17% | +$136K | ﹤0.01% | 2365 |
|
|
2016
Q1 | $986K | Buy |
116,000
+17,500
| +18% | +$149K | ﹤0.01% | 2352 |
|
|
2015
Q4 | $1.29M | Buy |
98,500
+12,900
| +15% | +$169K | ﹤0.01% | 2275 |
|
|
2015
Q3 | $314K | Hold |
85,600
| – | – | ﹤0.01% | 2811 |
|
|
2015
Q2 | $494K | Hold |
85,600
| – | – | ﹤0.01% | 2676 |
|
|
2015
Q1 | $500K | Hold |
85,600
| – | – | ﹤0.01% | 2623 |
|
|
2014
Q4 | $672K | Hold |
85,600
| – | – | ﹤0.01% | 2514 |
|
|
2014
Q3 | $421K | Hold |
85,600
| – | – | ﹤0.01% | 2648 |
|
|
2014
Q2 | $530K | Hold |
85,600
| – | – | ﹤0.01% | 2602 |
|
|
2014
Q1 | $458K | Hold |
85,600
| – | – | ﹤0.01% | 2616 |
|
|
2013
Q4 | $448K | Hold |
85,600
| – | – | ﹤0.01% | 2629 |
|
|
2013
Q3 | $501K | Hold |
85,600
| – | – | ﹤0.01% | 2546 |
|
|
2013
Q2 | $220K | Buy |
+85,600
| New | +$220K | ﹤0.01% | 2856 |
|